Form 4: Option Care Health CGO Sells Shares Under 10b5-1 Plan

Option Care Health's Chief Growth Officer, Christopher L. Grashoff, reported the sale of 2,486 common shares under a pre-arranged 10b5-1 plan.

Summary

• Christopher L. Grashoff, Chief Growth Officer of Option Care Health, Inc. (OPCH), reported the disposal of common stock.
• A total of 2,486 shares were disposed of across two transactions on February 20, 2026, and February 22, 2026.
• The shares were sold at a price of $35.69 per share.
• The transactions were executed under a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
• Following these transactions, Mr. Grashoff beneficially owns 46,072 shares of Option Care Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. The transactions are routine, pre-planned sales by an insider, likely for tax purposes, and do not suggest any significant positive or negative shift in the company's outlook or the executive's confidence.

Positives

• The transactions were conducted under a Rule 10b5-1(c) plan, which demonstrates a pre-planned and compliant approach to managing equity compensation, reducing concerns about opportunistic insider trading.

Negatives

• The sale of shares, even if for tax purposes, slightly reduces the direct equity alignment of a key executive with shareholder interests, though the amount is relatively small compared to total holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are a routine aspect of executive compensation and personal financial management across all industries. These pre-arranged sales are common for tax planning or diversification purposes and are generally not indicative of a change in company fundamentals.

Stakeholder Impact

• Shareholders: Minimal impact, as these are routine, pre-planned transactions by an insider and do not reflect a change in company fundamentals or a lack of confidence.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions executed under a pre-arranged 10b5-1 plan, likely for tax or personal financial planning. Such transactions are not typically indicative of a change in the company's fundamental performance or future prospects, nor do they suggest a shift in management's long-term view. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an investment thesis.

Keywords

Option Care Health, OPCH, Insider Trading, Form 4, Stock Sale, Chief Growth Officer, 10b5-1 Plan